StableEyes With Active Neurofeedback (SWAN)
Vestibular Disorder, Vestibular Schwannoma, Space Motion Sickness
About this trial
This is an interventional treatment trial for Vestibular Disorder
Eligibility Criteria
Inclusion Criteria: Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma Willing to adhere to the SWAN and/or vestibular rehabilitation regimen Exclusion Criteria: Current use of anti-nausea medication Presence of cervical spine pathology that limits head motion to < 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis) Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery) Legal blindness (20/200 or worse visual acuity) Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days
Sites / Locations
- Johns Hopkins UniversityRecruiting
- Naval Medical Research Unit
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
No Intervention
Traditional VPT JHU
SWAN VPT JHU
SWAN Motion Sick Dayton
Traditional Motion Sick Dayton
Subjects that have had their eighth cranial nerve resected will receive traditional vestibular rehabilitation exercises at Johns Hopkins University (JHU) site.
Subjects that have had their eighth cranial nerve resected will receive the automated vestibular rehabilitation method
Healthy control subjects that meet similar similar physical characteristics of astronauts will receive the automated vestibular rehabilitation method post motion sickness.
Typically, the suggestion for treating motion sickness once it has started is to avoid motion. Therefore, healthy control subjects that meet similar similar physical characteristics of astronauts will not receive any post motion sickness treatment.